Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2008
12/09/2008US7462369 Anti-viral compositions and methods of making and using the anti-viral compositions
12/09/2008US7462368 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino]butanoate
12/09/2008US7462362 10 weight % terbinafine hydrochloride, 0.5 % dodecyl 2-(N,N-dimethylamino)propionate hydrochloride and 0.75 % benzyl alcohol to enhance penetration; 0.5 % polyvinylpyrrolidone, and the remainder ethanol; duel delivery through nail and skin increases topical bioavailability; onychomycosis
12/09/2008US7462346 Photochemical demethylation reactions in solutions of thiazine dyes (dye molecules act as both sensitizer and substrate) are reduced by quenching triple-state dye molecules (incorporating zinc or sodium ions or both), returning them to the unreactive around state
12/09/2008CA2389650C Composition for treatment of constipation and irritable bowel syndrome
12/09/2008CA2387953C Compositions for electroporation
12/09/2008CA2387193C Compositions for electroporation
12/09/2008CA2326485C Anticancer compositions
12/09/2008CA2306486C Method and compositions for in situ formation of protective and/or medicated films on body tissue
12/09/2008CA2301017C Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
12/09/2008CA2215203C Vaccines for plague
12/09/2008CA2214737C Microparticles, media containing the latter for ultrasonic diagnosis as well as process for the production of the particles and media
12/09/2008CA2183151C Host-vector system for use in gene therapy
12/07/2008CA2590821A1 High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same
12/05/2008CA2631453A1 Glycoconjugates and their use as vaccine against shigella flexneri serotype 3a and x
12/04/2008WO2008148080A2 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin]
12/04/2008WO2008148057A2 Cationic lipids compositions and methods for enhancing immune responses to vaccines
12/04/2008WO2008148019A1 Methods of making and using nano scale particles
12/04/2008WO2008147765A1 Improved processes for making hydrazides
12/04/2008WO2008147534A1 Method for the treatment of neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant
12/04/2008WO2008147438A2 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
12/04/2008WO2008147245A2 Controlled release proxodolol pharmaceutical composition
12/04/2008WO2008146854A1 Paratope and epitope of anti-mortalin antibody
12/04/2008WO2008146841A1 Nucleic acid carrier for introduction of nucleic acid into cancer cell
12/04/2008WO2008146796A1 Medicated patch comprising 5-methyl-1-phenyl-2-(1h)-pyridone
12/04/2008WO2008146795A1 Percutaneously absorbable preparation
12/04/2008WO2008146732A1 Infusion solution for peripheral intravenous administration
12/04/2008WO2008146731A1 Method for preparation of infusion solution for peripheral intravenous administration
12/04/2008WO2008146590A1 Spherical mannitol crystal particle
12/04/2008WO2008146016A2 Cyclodextrins for administering fatty acids in tablets
12/04/2008WO2008145732A1 Stable non-aqueous pharmaceutical compositions
12/04/2008WO2008145730A1 Stable non-aqueous pharmaceutical compositions
12/04/2008WO2008145728A1 Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
12/04/2008WO2008145609A1 Method of making covalent conjugates with his-tagged proteins
12/04/2008WO2008145365A2 Treatment of surfactants with cyclodextrins
12/04/2008WO2008145359A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin
12/04/2008WO2008145338A2 Monoclonal antibodies against claudin-18 for treatment of cancer
12/04/2008WO2008145323A1 Pharmaceutical formulation for interferons
12/04/2008WO2008145142A1 Stable igg4 antibodies
12/04/2008WO2008145139A1 Fusion or linked proteins with extended half life
12/04/2008WO2008144996A1 Stable pharmaceutical cucurbitacin liquid composition
12/04/2008WO2008144942A1 Sesquiterpene formulations, kits and methods of use thereof
12/04/2008WO2008144919A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
12/04/2008WO2008144891A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144890A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144889A1 Humanized and chimeric anti-cd59 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144888A1 Formulations for the oral administration of therapeutic agents and related methods
12/04/2008WO2008144881A1 Biodegradable elastomers prepared by the condensation of an organic di-, tri- or tetra-carboxylic acid and an organic diol
12/04/2008WO2008144880A1 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
12/04/2008WO2008125800A3 Mmp activated vascular disrupting agents
12/04/2008WO2008124165A3 Self-assembling nanoparticle drug delivery system
12/04/2008WO2008116468A3 Mhc peptide complexes and uses thereof in infectious diseases
12/04/2008WO2008112836A3 Pharmaceutical composition comprising human growth hormon
12/04/2008WO2008109034A3 Modulating pdx-1 with pcif1, methods and uses thereof
12/04/2008WO2008079697A3 Method of treating mucin deficiency with an active pharmaceutical and related composition
12/04/2008WO2008079290A3 Stable buffered formulations containing polypeptides
12/04/2008WO2008076333A8 Polymer-drug conjugates with tether groups for controlled drug delivery
12/04/2008WO2008052145A3 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
12/04/2008WO2008015539A3 Topical preparation containing sirolimus for treating inflammatory skin deseases
12/04/2008WO2007133807A3 Polymers for functional particles
12/04/2008WO2007092161A3 A direct cellular energy delivery system
12/04/2008US20080300675 Polymeric stents and other surgical articles
12/04/2008US20080300322 Delivery vehicles containing rosin resins
12/04/2008US20080300320 Use of Polyvinyl Lactam-Polyalkylene Block Copolymers as Solubilisers for Poorly Water-Soluble Compounds
12/04/2008US20080300315 Stabilized Compositions Comprising a Therapeutically Active Agent, and an Oxidizing Preservative
12/04/2008US20080300296 Coating agent for drug releasing stent, preparation method thereof and drug releasing stent coated therewith
12/04/2008US20080300220 Linkable Lewis X Analogs
12/04/2008US20080300163 Modified Human Four Helical Bundle Polypeptides And Their Uses
12/04/2008US20080299536 Material and Methods for Nerve Grafting
12/04/2008US20080299220 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions
12/04/2008US20080299205 Particulate Constructs For Release of Active Agents
12/04/2008US20080299202 Controlled-Delivery System of Pharmacologically Active Substances, Preparation Process and Medical Use Thereof
12/04/2008US20080299199 Swellable Dosage Form Comprising Gellan Gum
12/04/2008US20080299198 Polystyrene sulfonate polymer tablets, their preparation and use
12/04/2008US20080299194 Pharmaceutical Formulation For Producing Rapidly Disintegrating Tablets
12/04/2008US20080299186 Coatings for applying substances onto substrate carrier
12/04/2008US20080299177 Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
12/04/2008US20080299176 Drug delivery device comprising crosslinked polyurethane-siloxane-containing copolymers
12/04/2008US20080299174 Bis-(Alpha-Amino)-Diol-Diester-Containing Poly (Ester Amide) and Poly (Ester Urethane) Compositions and Methods of Use
12/04/2008US20080299166 Novel biomaterials, their preparation and use
12/04/2008US20080299165 Compositions for Treatment of Diseases of the Nail Unit
12/04/2008US20080299164 Substituted polycaprolactone for coating
12/04/2008US20080299157 Skin care compositions having unique texture properties
12/04/2008US20080299156 Skin care compositions containing a high internal phase emulsion
12/04/2008US20080299071 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
12/04/2008US20080299069 Polymer Derivatives Comprising an Acetal or Ketal Branching Point
12/04/2008US20080299005 film made of water soluble polymer such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose, a reagent such as protein, hormone, antibody and an enzyme; film disintegrates upon contact with an aqueous fluid to release the reagent which reacts human chorionic gonadotrophin in saliva, urine, blood
12/04/2008US20080296196 Injection Molded Water-Soluble Container
12/04/2008CA2716159A1 Stable non-aqueous pharmaceutical compositions
12/04/2008CA2688570A1 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
12/04/2008CA2688486A1 Sesquiterpene formulations, kits and methods of use thereof
12/04/2008CA2688346A1 Compositions and methods for enhancing immune responses to vaccines
12/04/2008CA2688344A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
12/04/2008CA2688275A1 Stable igg4 antibodies
12/04/2008CA2688194A1 Antiviral drugs for treatment or prevention of dengue infection
12/04/2008CA2688164A1 Methods of making and using nano scale particles
12/04/2008CA2688036A1 Formulations for the oral administration of therapeutic agents and related methods
12/04/2008CA2687852A1 Improved processes for making hydrazides
12/04/2008CA2687794A1 Spherical particle of crystalline mannitol
12/04/2008CA2687586A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
1 ... 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 ... 1712